摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(2-aminoethyl) dimethylamine sulfonamide | 107674-92-0

中文名称
——
中文别名
——
英文名称
N-(2-aminoethyl) dimethylamine sulfonamide
英文别名
N'-(2-aminoethyl)-N,N-dimethylsulfamide;1-amino-2-(dimethylsulfamoylamino)ethane
N-(2-aminoethyl) dimethylamine sulfonamide化学式
CAS
107674-92-0
化学式
C4H13N3O2S
mdl
MFCD10024743
分子量
167.232
InChiKey
VXDUVINZNILVIC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    269.5±42.0 °C(Predicted)
  • 密度:
    1.235±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -1.7
  • 重原子数:
    10
  • 可旋转键数:
    4
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    83.8
  • 氢给体数:
    2
  • 氢受体数:
    5

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Ultra-short-acting .beta.-adrenergic receptor blocking agents. 3. Ethylenediamine derivatives of (aryloxy)propanolamines having esters on the aryl function
    摘要:
    Various ethylenediamine derivatives have been incorporated into the nitrogen substituent of certain short-acting (aryloxy)propanolamine systems that contain esters on their aryl functions. Although several of these compounds showed durations of action comparable to their prototypes, most of the nitrogen substituents significantly prolonged the duration of beta-adrenergic blockade. Similarly, while one of the compounds showed appreciable cardioselectivity in vitro, generally, little enhancement of cardioselectivity was obtained. A brief discussion of structure-activity relationships observed for the ethylenediamine derivatives is presented.
    DOI:
    10.1021/jm00362a004
点击查看最新优质反应信息

文献信息

  • CHEMICAL COMPOUNDS-821
    申请人:Finlay Maurice Raymond
    公开号:US20090048269A1
    公开(公告)日:2009-02-19
    The invention relates to chemical compounds of the formula (I), or pharmaceutically acceptable salts thereof, which possess ALK5 (TGFβR1) inhibitory activity and are accordingly useful for their anti-cancer activity and thus in methods of treatment of the human or animal body. The invention also relates to processes for the manufacture of said chemical compounds, to pharmaceutical compositions containing them and to their use in the manufacture of medicaments for use in the production of an anti-cancer effect in a warm-blooded animal such as man.
    该发明涉及化学式(I)的化合物,或其药学上可接受的盐,具有ALK5(TGFβR1)抑制活性,因此在抗癌活性方面有用,从而在治疗人体或动物体的方法中有用。该发明还涉及制造上述化学化合物的方法,含有它们的药物组合物,以及它们在制造用于在温血动物(如人)中产生抗癌效果的药物中的使用。
  • Amino substituted dibenzothiophene derivatives for the treatment of disorders mediated by np y5 receptor
    申请人:——
    公开号:US20030225097A1
    公开(公告)日:2003-12-04
    Compounds of formula (I): 1 wherein: X is a group of formula (A) or (B): 2 and R 1 , R 2 , R 3 , R 4 , n, x, y and z are as defined within are described. Processes for their preparation and their use in the treatment of disorders mediated by the neuropeptide Y5 receptor in a warm-blooded animal, such as a human being are also described.
    式(I)的化合物: 其中: X是式(A)或(B)的基团: 而R1、R2、R3、R4、n、x、y和z的定义如所述。 还描述了它们的制备过程以及它们在治疗由神经肽Y5受体介导的疾病中的用途,如在温血动物,如人类中的用途。
  • Design, synthesis and pharmacological evaluation of novel N-(2-(1, 1-dimethyl-5, 7-dioxo-4, 6-diazaspiro[2.4]heptan-6-yl)ethyl) sulfonamide derivatives as potential anticonvulsant agents
    作者:Jinping Li、Jun Lou、Zhiming Wang、Ting Wang、Yuling Xiao、Xianming Hu、Peng Liu、Xuechuan Hong
    DOI:10.1016/j.ejmech.2015.01.008
    日期:2015.3
    new N-(2-(1,1-dimethyl-5,7-dioxo-4,6-diazaspiro[2.4]heptan-6-yl)ethyl) sulfonamide derivatives (8a–i) and ethyl 2,2-dimethyl-1-(3-(2-(sulfonamido)ethyl)ureido) cyclopropanecarbox-ylate derivatives (9a–i) were designed, synthesized and evaluated for their anticonvulsant activities using maximal electroshock shock (MES) and subcutaneous pentylenetetrazole (scPTZ) seizure models in mice. N-(2-(1,1-dimethyl-5
    一系列新的N-(2-(1,1-二甲基-5,7-二氧代-4,6-二氮杂螺[2.4]庚-6-6基)乙基)磺酰胺衍生物(8a – i)和乙基2,2使用最大的电击休克(MES)和皮下戊四唑(scPTZ)设计,合成并评估了-二甲基-1-(3-(2-(磺酰胺基)乙基)脲基)环丙烷甲酸酯衍生物(9a – i)的抗惊厥活性。小鼠的癫痫发作模型。N-(2-(1,1-二甲基-5,7-二氧杂4,6-二氮杂螺[2.4]庚-6-6基)乙基)-4-氟苯甲磺酰胺(8f)和N-(2-( 1,1-二甲基-5,7-二氧代-4,6-二氮杂螺[2.4]庚-6-6基)乙基)-4-甲基苯磺酰胺(8e)已经在MES模型中显示出有希望的抗惊厥活性。活性最高的化合物8f在小鼠腹膜内注射后显示出MES诱发的癫痫发作,ED 50值为28.05 mg / kg,TD 50值为561 mg / kg,这为化合物8f提供了保护指数(TD 50 / ED
  • Design, synthesis and antibacterial activity evaluation of ebselen derivatives in NDM-1 producing bacteria
    作者:Wanli Meng、Chenyu Liu、Guangxin Wu、Zhongyue Bai、Zhihao Wang、Sheng Chen、Shengbiao Wan、Wandong Liu
    DOI:10.1039/d4md00031e
    日期:——
    restore the efficacy of meropenem (Mem) against NDM-1 producing strains. In this study, 22 compounds were designed and synthesized, which restored the Mem susceptibility of NDM-1-expressing Escherichia coli. and its minimum inhibitory concentration (MIC) was reduced by 2–16 times. Representative compound A4 showed significant synergistic antibacterial activity against NDM-1-producing carbapenem-resistant
    新德里-β-内酰胺酶-1 (NDM-1) 是一种金属-β-内酰胺酶。表达NDM-1的细菌可以通过质粒转移在全球范围内迅速传播,这极大地损害了碳青霉烯类药物的临床疗效。 NDM-1抑制剂的研究引起了广泛关注。然而,目前尚无临床可用的NDM-1抑制剂。我们的研究小组报道了1,2-benzisoselenazol-3(2 H )-one衍生物作为共价NDM-1抑制剂可以恢复美罗培南(Mem)对NDM-1产生菌株的功效。在这项研究中,设计并合成了22种化合物,恢复了表达NDM-1的大肠杆菌的Mem敏感性。其最低抑菌浓度(MIC)降低2~16倍。代表性化合物A4对产生 NDM-1 的碳青霉烯类耐药肠杆菌 (CRE) 分离株表现出显着的协同抗菌活性。体外NDM-1酶抑制活性测试显示IC 50为1.26±0.37 μM,具有较低的细胞毒性。与美罗培南合用时,表现出良好的联合抗菌活性。电喷雾电离质谱 (ESI-MS)
  • Ultra-short-acting .beta.-adrenergic receptor blocking agents. 3. Ethylenediamine derivatives of (aryloxy)propanolamines having esters on the aryl function
    作者:Paul W. Erhardt、Chi M. Woo、William L. Matier、Richard J. Gorczynski、William G. Anderson
    DOI:10.1021/jm00362a004
    日期:1983.8
    Various ethylenediamine derivatives have been incorporated into the nitrogen substituent of certain short-acting (aryloxy)propanolamine systems that contain esters on their aryl functions. Although several of these compounds showed durations of action comparable to their prototypes, most of the nitrogen substituents significantly prolonged the duration of beta-adrenergic blockade. Similarly, while one of the compounds showed appreciable cardioselectivity in vitro, generally, little enhancement of cardioselectivity was obtained. A brief discussion of structure-activity relationships observed for the ethylenediamine derivatives is presented.
查看更多